Dual blockade of IL-17A and IL-36 pathways via a bispecific antibody exhibits enhanced anti-inflammatory potency.
Ma X, Zhang S, Ren X, Feng Y, Li H, Chen S, Xu J, Wang Y, Peng GY, Yan Q, Jia H, Xia S, Cui X, Chen X, Pan X, Wang S, Yu H, Wei X, Li M, Liu B, Xu J, Qian Q, Zhu X, Zhan Y, Lu L.
Ma X, et al. Among authors: jia h.
Front Immunol. 2024 Nov 12;15:1434127. doi: 10.3389/fimmu.2024.1434127. eCollection 2024.
Front Immunol. 2024.
PMID: 39600699
Free PMC article.